Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jen-Yu Hung

Showing results (111-120 of 140) with videos related to

Pageof 14
Sort By:
Theranostics|August 31, 2023
Characterization of the pleural microenvironment niche and cancer transition using single-cell RNA sequencing in EGFR-mutated lung cancerYu-Yuan Wu, Ya-Ling Hsu, Yung-Chi Huang, et al.
Journal of Clinical Medicine|October 13, 2021
First-Line Anaplastic Lymphoma Kinase (ALK) Inhibitors for ALK-Positive Lung Cancer in Asian Populations: Systematic Review and Network Meta-AnalysisKuan-Li Wu, Hsiao-Ling Chen, Ying-Ming Tsai, et al.
Journal of Medicinal Food|February 9, 2010
Antiproliferative and antitumorigenic activity of Toona sinensis leaf extracts in lung adenocarcinomaChih-Jen Yang, Yu-Jung Huang, Cheng-Yuan Wang, et al.
The Kaohsiung Journal of Medical Sciences|June 17, 2025
Impact of Spread Through Air Spaces (STAS) on Recurrence and Surgical Trends in Stage I Non-Small Cell Lung Cancer: A Real-World Cohort StudyCheng-Hao Chuang, Yu-Wei Liu, Wei-An Lai, et al.
BMC Pulmonary Medicine|April 6, 2026
Surgical strategy and prognostic factors in very elderly (≥ 75 Years) patients with stage I NSCLC: insights from a propensity score-matched analysisJui-Ying Lee, Min-Fang Chao, Yi-Wen Shen, et al.
Cancers|November 27, 2024
Changes in Staging and Management of Non-Small Cell Lung Cancer (NSCLC) Patients Following the Implementation of Low-Dose Chest Computed Tomography (LDCT) Screening at Kaohsiung Medical University HospitalChin-Ling Chen, Jui-Sheng Hsu, Yi-Wen Shen, et al.
Lung Cancer (Amsterdam, Netherlands)|March 10, 2015
Liver metastasis predicts poorer prognosis in stage IV lung adenocarcinoma patients receiving first-line gefitinibKuan-Li Wu, Ming-Ju Tsai, Chih-Jen Yang, et al.
World Journal of Surgical Oncology|August 28, 2025
Prognostic significance of tumor spread through air spaces and lymphovascular invasion in stage I non-small cell lung cancer: implications for adjuvant chemotherapyTai-Huang Lee, Chia-Yu Kuo, Yi-Wen Shen, et al.
American Journal of Cancer Research|August 10, 2023
T790M detection rate after first-line combination therapy with bevacizumab and EGFR-TKIs in advanced NSCLC (TERRA Study)Chih-Hsi Scott Kuo, Po-Lan Su, Yu-Feng Wei, et al.
The Oncologist|March 11, 2022
Tyrosine Kinase Inhibitor Activity in Patients with NSCLC Harboring Uncommon EGFR Mutations: A Retrospective International Cohort Study (UpSwinG)Sanjay Popat, Te-Chun Hsia, Jen-Yu Hung, et al.
Pageof 14

Showing results (111-120 of 140) with videos related to

Sort By:
Pageof 14
Theranostics|August 31, 2023
Characterization of the pleural microenvironment niche and cancer transition using single-cell RNA sequencing in EGFR-mutated lung cancerYu-Yuan Wu, Ya-Ling Hsu, Yung-Chi Huang, et al.
Journal of Clinical Medicine|October 13, 2021
First-Line Anaplastic Lymphoma Kinase (ALK) Inhibitors for ALK-Positive Lung Cancer in Asian Populations: Systematic Review and Network Meta-AnalysisKuan-Li Wu, Hsiao-Ling Chen, Ying-Ming Tsai, et al.
Journal of Medicinal Food|February 9, 2010
Antiproliferative and antitumorigenic activity of Toona sinensis leaf extracts in lung adenocarcinomaChih-Jen Yang, Yu-Jung Huang, Cheng-Yuan Wang, et al.
The Kaohsiung Journal of Medical Sciences|June 17, 2025
Impact of Spread Through Air Spaces (STAS) on Recurrence and Surgical Trends in Stage I Non-Small Cell Lung Cancer: A Real-World Cohort StudyCheng-Hao Chuang, Yu-Wei Liu, Wei-An Lai, et al.
BMC Pulmonary Medicine|April 6, 2026
Surgical strategy and prognostic factors in very elderly (≥ 75 Years) patients with stage I NSCLC: insights from a propensity score-matched analysisJui-Ying Lee, Min-Fang Chao, Yi-Wen Shen, et al.
Cancers|November 27, 2024
Changes in Staging and Management of Non-Small Cell Lung Cancer (NSCLC) Patients Following the Implementation of Low-Dose Chest Computed Tomography (LDCT) Screening at Kaohsiung Medical University HospitalChin-Ling Chen, Jui-Sheng Hsu, Yi-Wen Shen, et al.
Lung Cancer (Amsterdam, Netherlands)|March 10, 2015
Liver metastasis predicts poorer prognosis in stage IV lung adenocarcinoma patients receiving first-line gefitinibKuan-Li Wu, Ming-Ju Tsai, Chih-Jen Yang, et al.
World Journal of Surgical Oncology|August 28, 2025
Prognostic significance of tumor spread through air spaces and lymphovascular invasion in stage I non-small cell lung cancer: implications for adjuvant chemotherapyTai-Huang Lee, Chia-Yu Kuo, Yi-Wen Shen, et al.
American Journal of Cancer Research|August 10, 2023
T790M detection rate after first-line combination therapy with bevacizumab and EGFR-TKIs in advanced NSCLC (TERRA Study)Chih-Hsi Scott Kuo, Po-Lan Su, Yu-Feng Wei, et al.
The Oncologist|March 11, 2022
Tyrosine Kinase Inhibitor Activity in Patients with NSCLC Harboring Uncommon EGFR Mutations: A Retrospective International Cohort Study (UpSwinG)Sanjay Popat, Te-Chun Hsia, Jen-Yu Hung, et al.
Pageof 14